[1]张浩强,叶超,毛露,等.血管紧张素转换酶2-血管紧张素（1-7）-Mas受体轴与高血压的相关性研究[J].心血管病学进展,2021,(2):141.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.012]
　ZHANG Haoqiang,YE Chao,MAO Lu,et al.Relationship Between Angiotensin Converting Enzyme 2-angiotensin(1-7)-Mas Receptor Axis and Hypertension[J].Advances in Cardiovascular Diseases,2021,(2):141.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.012]
点击复制

血管紧张素转换酶2-血管紧张素（1-7）-Mas受体轴与高血压的相关性研究()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2021年2期
页码:
141
栏目:
综述
出版日期:
2021-02-25

文章信息/Info

Title:
Relationship Between Angiotensin Converting Enzyme 2-angiotensin(1-7)-Mas Receptor Axis and Hypertension
作者:
张浩强1 ; 叶超1;  毛露2;  Dirk Hermann3;  陈艾东1; 3
南京医科大学心血管病靶向干预重点实验室,江苏 南京 211166;2. 东南大学附属中大医院,江苏 南京 210096;3. 杜伊斯堡-埃森大学神经生物学研究中心,德国 埃森 45122
Author(s):
ZHANG Haoqiang1;  YE Chao1;  MAO Lu2;  Dirk Hermann3;  CHEN Aidong1; 3
Key Laboratory of Targeting Interventions for Cardiovascular Diseases,Nanjing Medical University,Nanjing 211166,Jiangsu,China; 2. Zhongda Hospital Affiliated to Southeast University,Nanjing 210096,Jiangsu,China; 3. Center for Neurobiology,Duisburg-Essen University,Essen 45122,Germany) ( 3157116881571246)(20173059)(2016M5917502017T100320). E-mail: aidongchen@njmu.edu.cn
关键词:
血管紧张素转换酶2; 血管紧张素（1-7）; Mas受体; 高血压
Keywords:
Angiotensin converting enzyme 2;  Angiotensin (1-7);  Mas receptor;  Hypertension
DOI:
10.16806/j.cnki.issn.1004-3934.2021.02.012
摘要:
高血压发病率高，是全球范围内的重大的慢性疾病，由它引发的心脑血管的并发症发病率和死亡率一直非常高。目前，本病的治疗效果不够理想，研究发现各种类型的高血压均有不同程度的肾素-血管紧张素（RAS）系统过度增强现象，但其机制尚不清楚，其成为迫切需解决的重要科学问题。近期对血管紧张素转换酶2-血管紧张素（1-7）-Mas受体轴各成员及整个完整的肾素-血管紧张素系统深入研究和阐述，为治疗本病找到新的药物靶点提供了方向，本文就此做一系统阐述。
Abstract:
The high incidence of hypertension is a major chronic disease in the world. The morbidity and mortality of cardiovascular and cerebrovascular complications caused by hypertension are always very high. At present,the treatment effect of this disease is not ideal,studies have found that various types of hypertension have different degrees of excessive renin-angiotensin system (RAS) activity phenomenon,but the mechanism is not clear. This has become an important scientific problem that urgently needs to be solved. Recently,the members of angiotensin converting enzyme 2-angiotensin (1-7)-mas receptor axis and the whole RAS have been deeply studied and elaborated,which provides directions for finding new drug targets for the treatment of this disease.This paper makes a systematic review for these

参考文献/References:


[1] Xu J,Fan J,Wu F,et al. The ACE2/angiotensin-(1-7)/mas receptor axis:pleiotropic roles in cancer[J]. Front Physiol,2017,8:276-283.

[2] Fan R,Mao SQ,Gu TL,et al. Preliminary analysis of the association between methylation of the ACE2 promoter and essential hypertension[J]. Mol Med Rep,2017,15(6):3905-3911.

[3] Pinheiro DS,Santos RS,Jardim P,et al. The combination of ACE I/D and ACE2 G8790A polymorphisms revels susceptibility to hypertension:A genetic association study in Brazilian patients[J].PLoS One,2019,14(8):e0221248.

[4] Fan Z,Wu G,Yue M,et al. Hypertension and hypertensive left ventricular hypertrophy are associated with ACE2 genetic polymorphism[J]. Life Sci,2019,225:39-45.

[5] 张瑞,毛露,孙硕,等. 内皮素-1干预成为高血压治疗新靶点的展望[J ]. 心血管病学进展,2019,40(7):969-972.

[6] Luo Y,Liu C,Guan T,et al. Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang[J]. Hypertens Res,2019,42(5):681-689.

[7] Yu J,Wu Y,Zhang Y,et al. Role of ACE2-Ang (1-7)-Mas receptor axis in heart failure with preserved ejection fraction with hypertension[J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban ,2018,43(7):738-746.

[8] Soler MJ,Batlle M,Riera M,et al. ACE2 and ACE in acute and chronic rejection after human heart transplantation[J]. Int J Cardiol,2019,275:59-64.

[9] Yang CW,Lu LC,Chang CC,et al. Imbalanced plasma ACE and ACE2 level in the uremic patients with cardiovascular diseases and its change during a single hemodialysis session [J]. Ren Fail,2017,39(1):719-728.

[10] Xu J,Sriramula S,Xia H,et al. Clinical relevance and role of neuronal AT1 receptors in ADAM17-mediated ACE2 shedding in neurogenic hypertension[J].Circ Res,2017,121(1):43-55.

[11] Yang P,Kuc RE,Brame AL,et al. [Pyr1]Apelin-13(1-12) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr 1]Apelin-13[J]. Front Neurosci ,2017,11:92.

[12] Wu X,Zhu B,Zou S,et al. The association between ACE2 gene polymorphism and the stroke recurrence in Chinese population [J]. J Stroke Cerebrovasc Dis ,2018,27(10):2770-2780.

[13] Stoll D,Yokota R,Sanches Arag?o D,et al. Both aldosterone and spironolactone can modulate the intracellular ACE/ANG II/AT1 and ACE2/ANG (1-7)/MAS receptor axes in human mesangial cells[J]. Physiol Rep ,2019,7(11):e14105.

[14] Gonzalez AA,Gallardo M,Cespedes C,et al. Potassium intake prevents the induction of the renin-angiotensin system and increases medullary ACE2 and COX-2 in the kidneys of angiotensin II-dependent hypertensive rats[J]. Front Pharmacol ,2019,10:1212.

[15] Hekmat AS,Zare N,Moravej A,et al. Effect of prolonged infusion of alamandine on cardiovascular parameters and cardiac ACE2 expression in a rat model of renovascular hypertension [J]. Biol Pharm Bull ,2019,42(6):960-967.

[16] Hu Q,Hu Z,Chen Q,et al. BML-111 equilibrated ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis to protect hepatic fibrosis in rats[J]. Prostaglandins Other Lipid Mediat ,2017,131:75-82.

[17] Feng Q,Hui J,Tang N,et al. Unexpected role of the human cytomegalovirus contribute to essential hypertension in the Kazakh Chinese population of Xinjiang[J]. Biosci Rep ,2018,38(3):BSR20171522..

[18] Sharma RK,Verma M,Tiwari RM,Jet al. Prevalence and real-world assessment of central aortic blood pressure in adult patients with essential hypertension uncontrolled on single anti-hypertensive agents[J]. Indian Heart J ,2018,70(Suppl 3):S213-S220.

[19] Zhang L,Wang J,Liang J,et al. Propofol prevents human umbilical vein endothelial cell injury from AngⅡ-induced apoptosis by activating the ACE2-(1-7)-Mas axis and eNOS phosphorylation[J]. PLoS One ,2018,13(7):e0199373.

[20] Sriramula S,Pedersen KB,Xia H,et al. Determining the enzymatic activity of angiotensin-converting enzyme 2 (ACE2) in brain tissue and cerebrospinal fluid using a quenched fluorescent substrate[J]. Methods Mol Biol ,2017,1527:117-126.

相似文献/References:

[1]陈捷?王宏宇.新型冠状病毒肺炎患者心血管损伤机制研究进展[J].心血管病学进展,2021,(5):401.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.004]
　CHEN Jie,WANG Hongyu?/html>.Mechanism of Cardiovascular Damage in Patients with Corona Virus Disease 2019[J].Advances in Cardiovascular Diseases,2021,(2):401.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.004]

备注/Memo

备注/Memo:
基金项目：国家自然科学基金面上项目（ 31571168，81571246）；国家公派留学基金（20173059）；中国博士后基金（2016M591750和2017T100320）通讯作者：陈艾东，E-mail: aidongchen@njmu.edu.cn
更新日期/Last Update: 2021-06-15